News | April 15, 2026
Vetter ramps up global clinical manufacturing push with major US & Europe expansion
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
This transaction fundamentally strengthens Scinai's CDMO platform
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Subscribe To Our Newsletter & Stay Updated
